Dyne Therapeutics, Inc.

DYN

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001818794

SEC filings (opens in a new tab)

In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Dyne Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of DYN: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	93	94	+1
Shares	47.8M	47.7M	−63.1K (−0.1%)
Value	$568.3M	$456.6M	−$111.7M (−19.7%)

New holders (11)

Institutions that held Dyne Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to DYN in Q1 2022
Institution	Shares	Value	% of portfolio
Alliancebernstein L.P.	183,300	$1.77M	0.00%
HighVista Strategies LLC	168,691	$1.63M	1.03%
Barclays PLC	19,186	$185.0K	0.00%
Parametric Portfolio Associates LLC	10,113	$97.0K	0.00%
Amalgamated Bank	3,631	$35.0K	0.00%
Amalgamated Financial Corp.	3,631	$35.0K	0.00%
Point72 Hong Kong Ltd	586	$6.00K	0.00%
US Bancorp	407	$4.00K	0.00%
Lindbrook Capital, LLC	437	$4.00K	0.00%
Signaturefd, LLC	71	$1.00K	0.00%
Meeder Asset Management Inc	4	$0	0.00%

Sold out (10)

Institutions that held Dyne Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of DYN in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Great Point Partners LLC	845,000	$10.0M
Soleus Capital Management, L.P.	338,760	$4.03M
Altium Capital Management LP	166,636	$1.98M
Sphera Funds Management Ltd.	105,204	$1.25M
Martingale Asset Management L P	31,814	$379.0K
Trexquant Investment LP	20,232	$241.0K
Jump Financial, LLC	19,100	$227.0K
FourThought Financial, LLC	671	$8.00K
Federated Hermes, Inc.	341	$4.00K
Washington Trust Advisors, Inc.	63	$1.00K